IRIS

HMGB1 is increased in adolescents with polycystic ovary syndrome (PCOS) and decreases after treatment with myo-inositol (MYO) in combination with alpha-lipoic acid (ALA) / Cirillo, F; Catellani, C; Lazzeroni, P; Sartori, C; Tridenti, G; Vezzani, C; Fulghesu, Am; Madeddu, E; Amarri, S; Street, M. - In: GYNECOLOGICAL ENDOCRINOLOGY. - ISSN 1473-0766. - (2020).

HMGB1 is increased in adolescents with polycystic ovary syndrome (PCOS) and decreases after treatment with myo-inositol (MYO) in combination with alpha-lipoic acid (ALA)

STREET M
2020-01-01
2020
HMGB1 is increased in adolescents with polycystic ovary syndrome (PCOS) and decreases after treatment with myo-inositol (MYO) in combination with alpha-lipoic acid (ALA) / Cirillo, F; Catellani, C; Lazzeroni, P; Sartori, C; Tridenti, G; Vezzani, C; Fulghesu, Am; Madeddu, E; Amarri, S; Street, M. - In: GYNECOLOGICAL ENDOCRINOLOGY. - ISSN 1473-0766. - (2020).
1.1 Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2905096
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 21
  • ???jsp.display-item.citation.isi??? 21
social impact